Serina Therapeutics
Serina develops small molecules, RNA-based therapeutics, and antibody-drug conjugates for neurological diseases using its POZ Platform.
8-KNov 12Latest SEC filing
Nov 12Latest story
November 2026
August 2026
July 2026
Serina develops small molecules, RNA-based therapeutics, and antibody-drug conjugates for neurological diseases using its POZ Platform.
November 2026
August 2026
July 2026